Your browser doesn't support javascript.
loading
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Ladenstein, Ruth; Pötschger, Ulrike; Valteau-Couanet, Dominique; Luksch, Roberto; Castel, Victoria; Yaniv, Isaac; Laureys, Genevieve; Brock, Penelope; Michon, Jean Marie; Owens, Cormac; Trahair, Toby; Chan, Godfrey Chi Fung; Ruud, Ellen; Schroeder, Henrik; Beck Popovic, Maja; Schreier, Guenter; Loibner, Hans; Ambros, Peter; Holmes, Keith; Castellani, Maria Rita; Gaze, Mark N; Garaventa, Alberto; Pearson, Andrew D J; Lode, Holger N.
Affiliation
  • Ladenstein R; St Anna Children's Hospital, Vienna, Austria; Department for Studies and Statistics and Integrated Research, Vienna, Austria; Children's Cancer Research Institute, Vienna, Austria. Electronic address: ruth.ladenstein@ccri.at.
  • Pötschger U; Department for Studies and Statistics and Integrated Research, Vienna, Austria; Children's Cancer Research Institute, Vienna, Austria.
  • Valteau-Couanet D; Children and Adolescent Oncology Department, Gustave Roussy, Paris-Sud University, Paris, France.
  • Luksch R; Department di Ematologica e Onco-Ematologica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Castel V; Pediatric Oncology Unit, Hospital Universitario y Politecnico La Fe, Valencia, Spain.
  • Yaniv I; Pediatric Oncology Unit, Schneider Children's Medical Center of Israel, Sackler Faculty of Medicine Tel Aviv University, Petach Tikvah, Israel.
  • Laureys G; Department of Pediatric Hematology/Oncology and Stem Cell Transplantation University Hospital Ghent, Ghent, Belgium.
  • Brock P; Department of Pediatric Oncology, Great Ormond Street Hospital, London, UK.
  • Michon JM; Children, Adolescent and Young Adults Department, Institut Curie, Paris, France.
  • Owens C; Department of Haemato-Oncology, Our Lady's Children's Hospital, Dublin, Ireland.
  • Trahair T; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.
  • Chan GCF; Department of Paediatrics & Adolescent Medicine, Queen Mary Hospital, Hong Kong.
  • Ruud E; Department of Paediatric Medicine, Rikshospitalet, Oslo, Norway.
  • Schroeder H; Department of Paediatrics, University Hospital of Aarhus, Aarhus, Denmark.
  • Beck Popovic M; Department of Paediatrics and Paediatric Surgery, Paediatric Haematology Oncology Unit, University Hospital Lausanne, Switzerland.
  • Schreier G; Centre for Health and Bioresources, AIT Austrian Institute of Technology GmbH, Graz, Austria.
  • Loibner H; Apeiron Biologics AG, Vienna, Austria.
  • Ambros P; Department of Biology, Vienna, Austria; Children's Cancer Research Institute, Vienna, Austria.
  • Holmes K; Department of Paediatric Surgery, St George's Hospital, London, UK.
  • Castellani MR; Department di Ematologica e Onco-Ematologica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gaze MN; Department of Oncology, University College London Hospitals NHS Foundation Trust, National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK.
  • Garaventa A; Oncology Unit, Istituto Giannina Gaslini, Genoa, Italy.
  • Pearson ADJ; Paediatric and Adolescent Drug Development Team, Oak Centre for Children and Young People, Institute of Cancer Research, Royal Marsden Hospital, Sutton, UK.
  • Lode HN; Paediatric Haematology-Oncology Department, University Medicine Greifswald, Greifswald, Germany.
Lancet Oncol ; 19(12): 1617-1629, 2018 12.
Article in En | MEDLINE | ID: mdl-30442501
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Interleukin-2 / Antibodies, Monoclonal / Neuroblastoma Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Interleukin-2 / Antibodies, Monoclonal / Neuroblastoma Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Country of publication: